Aarti Pharmalabs Limited (AARTIPHARM.BO)

INR 642.25

(-1.17%)

Long Term Debt Summary of Aarti Pharmalabs Limited

  • Aarti Pharmalabs Limited's latest annual long term debt in 2023 was 400 Thousand INR , down -94.37% from previous year.
  • Aarti Pharmalabs Limited's latest quarterly long term debt in 2024 Q2 was 1.01 Billion INR , down 0.0% from previous quarter.
  • Aarti Pharmalabs Limited reported annual long term debt of 7.1 Million INR in 2022, up 28.04% from previous year.
  • Aarti Pharmalabs Limited reported annual long term debt of 5.54 Million INR in 2021, up 2869.19% from previous year.
  • Aarti Pharmalabs Limited reported quarterly long term debt of - INR for 2024 Q1, down -100.0% from previous quarter.
  • Aarti Pharmalabs Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Aarti Pharmalabs Limited (2023 - 2019)

Historical Annual Long Term Debt of Aarti Pharmalabs Limited (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 400 Thousand INR -94.37%
2022 7.1 Million INR 28.04%
2021 5.54 Million INR 2869.19%
2020 186.75 Thousand INR 0.0%
2019 186.75 Thousand INR 0.0%

Peer Long Term Debt Comparison of Aarti Pharmalabs Limited

Name Long Term Debt Long Term Debt Difference
Alembic Pharmaceuticals Limited 628.8 Million INR 99.936%
Aurobindo Pharma Limited 21.34 Billion INR 99.998%
Glenmark Life Sciences Limited 147.61 Million INR 99.729%
Granules India Limited 689.71 Million INR 99.942%
Indoco Remedies Limited 3.51 Billion INR 99.989%
Achyut Healthcare Limited - INR -Infinity%
Ajanta Pharma Limited 235.2 Million INR 99.83%
Alkem Laboratories Limited 400 Million INR 99.9%
Alpa Laboratories Limited - INR -Infinity%
Brooks Laboratories Limited 3.56 Million INR 88.78%
AstraZeneca Pharma India Limited 27.83 Million INR 98.563%
Bajaj HealthCare Limited 650.34 Million INR 99.938%
Bliss GVS Pharma Limited 355.92 Million INR 99.888%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.993%
Eris Lifesciences Limited 6.54 Billion INR 99.994%
FDC Limited 2.46 Million INR 83.779%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 99.974%
Gufic Biosciences Limited 1.53 Billion INR 99.974%
Ind-Swift Laboratories Limited 111.62 Million INR 99.642%
Ipca Laboratories Limited 5.8 Billion INR 99.993%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 99.471%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 99.978%
Lasa Supergenerics Limited - INR -Infinity%
Laurus Labs Limited 8.6 Billion INR 99.995%
Lupin Limited 1.55 Billion INR 99.974%
Mankind Pharma Limited 248.67 Million INR 99.839%
Medicamen Biotech Limited 12.55 Million INR 96.814%
Medico Remedies Limited 8.67 Million INR 95.387%
Megasoft Limited 1.35 Billion INR 99.971%
NATCO Pharma Limited 53 Million INR 99.245%
Piramal Pharma Limited 24.83 Billion INR 99.998%
RPG Life Sciences Limited -30.3 Million INR 101.32%
Sigachi Industries Limited 265.79 Million INR 99.85%
Sun Pharmaceutical Industries Limited 13.3 Million INR 96.992%
Suven Pharmaceuticals Limited 212.35 Million INR 99.812%
Syncom Formulations (India) Limited -1.21 Million INR 132.814%
Unichem Laboratories Limited 382.22 Million INR 99.895%
Wanbury Limited 820 Million INR 99.951%
Windlas Biotech Limited 20.18 Million INR 98.018%
ZIM Laboratories Limited 356 Million INR 99.888%
Zydus Lifesciences Limited 251 Million INR 99.841%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 99.625%
Divi's Laboratories Limited 20 Million INR 98.0%
Hester Biosciences Limited 1.81 Billion INR 99.978%
Procter & Gamble Health Limited 68.8 Million INR 99.419%
Amrutanjan Health Care Limited 13.96 Million INR 97.136%
Bal Pharma Limited 363.82 Million INR 99.89%
Strides Pharma Science Limited 6.71 Billion INR 99.994%
Venus Remedies Limited 386.8 Million INR 99.897%
Nectar Lifesciences Limited 1.4 Billion INR 99.971%
Shilpa Medicare Limited 5.6 Billion INR 99.993%
Aarti Drugs Limited 2.75 Billion INR 99.985%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Suven Life Sciences Limited - INR -Infinity%
Ind-Swift Limited 10.09 Billion INR 99.996%
Valiant Laboratories Limited 746.63 Million INR 99.946%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 99.831%
Solara Active Pharma Sciences Limited 1.05 Billion INR 99.962%
Themis Medicare Limited 267.74 Million INR 99.851%
Hikal Limited 4.22 Billion INR 99.991%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.998%
Sequent Scientific Limited 1.42 Billion INR 99.972%
Novartis India Limited 50.7 Million INR 99.211%
Wockhardt Limited 8.91 Billion INR 99.996%
Jubilant Pharmova Limited 31.67 Billion INR 99.999%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
Neuland Laboratories Limited 449.2 Million INR 99.911%
Morepen Laboratories Limited 33.64 Million INR 98.811%
Kilitch Drugs (India) Limited - INR -Infinity%
Mangalam Drugs & Organics Limited 133.54 Million INR 99.7%